SKI Market

A+| A| A-|

Indian Indices

Sensex

76,585.02 -170.03
( -0.22%)

Global Indices

Nasdaq

52,250.80 5.16
(0.01%)

Dow Jones

7,521.33 -8.87
(-0.12%)

Hang Seng

66,164.55 -67.64
(-0.10%)

Nikkei 225

10,722.03 136.12
(1.29%)

Forex

USD-INR

96.31 -0.12
(-0.13%)

EUR-INR

109.90 -0.27
(-0.25%)

GBP-INR

129.11 -0.56
(-0.43%)

JPY-INR

0.59 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

13.06

16743.19

EPS(TTM)

Face Value()

Div & Yield %

71.55

0.53

Back

Board of Mangalam Worldwide recommends final dividend

Apr 30,2026

Mangalam Worldwide announced that the Board of Directors of the Company at its meeting held on 29 April 2026, inter alia, have recommended the final dividend of Rs 0.3 per equity Share (i.e. 3%) , subject to the approval of the shareholders.

76,585.02 -170.03 ( -0.22%)

52,250.80 5.16 (0.01%)

7,521.33 -8.87 (-0.12%)

66,164.55 -67.64 (-0.10%)

10,722.03 136.12 (1.29%)

96.31 -0.12 (-0.13%)

109.90 -0.27 (-0.25%)

129.11 -0.56 (-0.43%)

0.59 0.00 (-0.36%)